D-Tetrandrine

D-Tetrandrine Struktur
518-34-3
CAS-Nr.
518-34-3
Englisch Name:
D-Tetrandrine
Synonyma:
TETRANDRINE;hanfangchin A;Conba;Jinake;Trandrine;fanchinine;TETRANDRIN;Tetradrine;sinomeninea;Tetrantrine
CBNumber:
CB9855050
Summenformel:
C38H42N2O6
Molgewicht:
622.75
MOL-Datei:
518-34-3.mol

D-Tetrandrine Eigenschaften

Schmelzpunkt:
219-222 °C(lit.)
Siedepunkt:
662.81°C (rough estimate)
alpha 
285 º (c=1, CHCl3)
Dichte
1.1528 (rough estimate)
Brechungsindex
1.5300 (estimate)
storage temp. 
2-8°C
Löslichkeit
Chloroform (Slightly), Methanol (Slightly, Heated)
Aggregatzustand
solid
pka
7.70±0.20(Predicted)
Farbe
Off-White
maximale Wellenlänge (λmax)
283nm(EtOH)(lit.)
Merck 
14,9231
LogP
3.550 (est)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xi
R-Sätze: 36/37/38
S-Sätze: 22-24/25-36-26
WGK Germany  3
RTECS-Nr. XE9350000
HS Code  29349990
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H300 Lebensgefahr bei Verschlucken. Akute Toxizität oral Kategorie 2 Achtung GHS hazard pictogramssrc="/GHS06.jpg" width="20" height="20" /> P264, P270, P301+P310, P321, P330,P405, P501
Sicherheit
P264 Nach Gebrauch gründlich waschen.
P264 Nach Gebrauch gründlich waschen.
P270 Bei Gebrauch nicht essen, trinken oder rauchen.
P301+P310 BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P405 Unter Verschluss aufbewahren.
P501 Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.

D-Tetrandrine Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.

S-Sätze Betriebsanweisung:

S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.

Beschreibung

Recently it has been discovered that pronounced drug-dependence and related toxic effects occur in both dogs and rhesus monkeys with this alkaloid on intravenous injection with a dose of 10-150 mg/kg. When rapidly injected, the acute hypotensive effect is very marked and fatal at once. Following drug administration at toxic levels it is found that severe local tissue reaction heptaotoxicity and lymphoid necrosis occurs. At the highest dosage level there is a very definite nephrotoxicity in monkeys and some indications of this in dogs. The evidence available suggests that monkeys are less sensitive to hepatotoxicity with this drug than dogs.

Chemische Eigenschaften

White powder

Physikalische Eigenschaften

Appearance: Needle-like crystals (ether). Solubility: Hardly soluble in water and petroleum ether; soluble in ether and some organic solvents. Melting point: 219– 222?°C. Specific optical rotation: 285° (c?=?1, CHCl3); sensitive to light.

History

Recent studies have shown that tetrandrine has a variety of biological effects and very good applicational prospects in the treatment of fibrosis and portal vein and pulmonary hypertension, the regulation of immunologic function, as well as the prevention and treatment of tumor.
As early as 1988, tetrandrine has been found having the effect on blocking the Ca2 + channel and was quickly applied into the pharmacological research in the field of cardiovascular and inflammatory diseases. Results from a large number of studies have shown that tetrandrine has good effects on antihypertension, arrhythmia, myocardial ischemia, inflammation, and so on. As a traditional Chinese calcium antagonist, tetrandrine has a broad prospects in clinical applications of cardiovascular and inflammatory diseases.In the early 1990s, the application of tetrandrine was extended. During that time, researchers conducted many studies about its protective effects on liver, lung, and mitochondria, which opened a new field for the treatment of liver disease. In 2002, it was found that tetrandrine can inhibit the synthesis of DNA and RNA in tumor cells, which provided a new method for the treatment of cancer. At present, the prevention and treatment effects of hypertension, fibrosis, digestive diseases, tumors, rheumatoid arthritis, and other autoimmune diseases of tetrandrine have been confirmed, as well as the function of reducing portal hypertension and pulmonary hypertension, while its other pharmacological effects are to be explored in further study.

Verwenden

analgesic, antineoplastic, antihypertensive, lymphotoxin

Indications

This product is included in national standards for chemical drugs (Volume 14), British Pharmacopoeia (2017), and European Pharmacopoeia (9.0th ed.). Tetrandrine is used for the treatment of mild to moderate hypertension and hypertensive crisis, rheumatism, silicosis, etc.

Pharmakologie

Tetrandrine has analgesic, anti-inflammatory, and anti-allergic effects and has a wide range of usage on the cardiovascular system owing to its antihypertensive, anti-myocardial ischemia/reperfusion injury and antiarrhythmic effects. It can inhibit the platelet aggregation induced by ADP, collagen, and arachidonic acid in?vitro and can also restrain the platelet adhesion and thrombosis (in rabbits). Tetrandrine also has anticancer effects. Studies have shown that tetrandrine has a strong inhibitory effect on the DNA and RNA synthesis in L7712 and S180 (cancer cells), which can significantly suppress the growth of Wacker sarcoma W256. Besides that, tetrandrine has the ability to relax the striated muscle, and its methyl iodide or methyl bromide derivatives can also affect the muscles. Notably, tetrandrine can prevent silicosis and has a preferable outcome on the clinical treatment of such disease. In addition, tetrandrine also owns antipyretic, diuretic, and antiallergic shock effects.

Clinical Use

Tetrandrine is used for the treatment of hypertension, angina, termination of paroxysmal supraventricular tachycardia, pulmonary fibrosis, and other diseases in clinical application, and it also has strong antitumor effects. Tetrandrine was also approved for lowering blood glucose and free radical damage; its treatment effect on silicosis is significant and superior to conventional immunosuppressive and cytotoxic drugs.

Einzelnachweise

Gralla, Coleman, Jonas, Cancer Chemother. Rep., Pt. 3, 5(1), 79 (1974)

D-Tetrandrine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


D-Tetrandrine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 414)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Mojin Biotechnology Co., Ltd
+86 13288715578 +8613288715578
sales@hbmojin.com China 12446 58
Hebei Yanxi Chemical Co., Ltd.
+8617531190177
peter@yan-xi.com China 5873 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21667 55
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3620 58
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29888 58
Chengdu Biopurify Phytochemicals Ltd.
+8618080483897
sales@biopurify.com China 3772 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Cangzhou Wanyou New Material Technology Co.,Ltd
18631714998
sales@czwytech.com CHINA 906 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845
sales@amoychem.com China 6387 58
Shaanxi Pioneer Biotech Co., Ltd .
+8613259417953
sales@pioneerbiotech.com China 3000 58

518-34-3()Verwandte Suche:


  • [4aS-(4aR*,16aR*)]-3,4,4a,5,16a,17,18,19-Octahydro-12,21,22,26-tetramethoxy-4,17-dimethyl-16H-1,24:6,9-dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline
  • (S S)-(+)-TETRANDRINE 98%
  • Conba
  • Jinake
  • (1β)-6,6',7,12-tetramethoxy-2,2'-dimethylberbaman
  • TETRANDRINE, (S,S)-(+)-(RG)
  • Trandrine
  • 16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline,3,4,4a,5, 16a,17,18,19-octahydro-12,21,22,26-
  • tetramethoxy-4,17-dimethyl-,(4aS,16aS)-
  • 6,6',7,12-Tetramethoxy-2,2'-dimethyl-9',10',11',12',13',14'-hexadehydro-9',10',11',12',13',14'-hexahydroberbaman
  • Tetrandrine(Fanchinine)
  • Tetrandrine(Fanchinine,NSC 77037)
  • 16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline, 3,4,4a,5,16a,17,18,19-octahydro-12,21,22,26-tetramethoxy-4,17-dimethyl-, (4aS,16aS)-
  • D-Tetrandrine 6,6',7,12-Tetramethoxy-2,2'-dimethyl-1-beta-berbaman
  • 6’,7,12-tetramethoxy-2,2’-dimethyl-(1-beta)-berbama
  • fanchinine
  • sinomeninea
  • 6,6',7,12-tetramethoxy-2,2'-dimethyl-1-beta-berbaman
  • 6,6',7,12-TETRAMETHOXY-2,2'-DIMETHYLBERBAMAN
  • (1B)-6,6',7,12-TETRAMETHOXY-2,2'-DIMETHYLBERBAMAN
  • d-tetrandrine
  • (S,S)-(+)-TETRANDRINE
  • TETRANDRIN
  • (+)-TETRANDRINE
  • TETRANDRINE, (S,S)-(+)
  • 6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-3,4-dihydro-1H-isoquinoline
  • 6-methoxy-2-methyl-1-(phenylmethyl)-3,4-dihydro-1H-isoquinoline
  • Tetrandrine 518-34-3
  • Tetrandrine, 98%, from fourstamen stephania root
  • Tetrandrine CRS
  • (1beta)-6,6',7,12-Tetramethoxy-2,2'-dimethylberbaman
  • TetrandrineDimethiodide USP/EP/BP
  • D-Tetrandrine USP/EP/BP
  • Water-soluble powder tetrandrine
  • Tetrandrine (NSC-77037)
  • TIANFU-CHEM D-Tetrandrine
  • Tetrandrine/tetrandrine
  • Water-soluble tetrandrine
  • Stephania Tetrandra extract Tetrandrine
  • TETRANDRINE
  • hanfangchin A
  • Tetrantrine
  • Tetradrine
  • (11S,31S)-16,36,37,54-Tetramethoxy-12,32-dimethyl-11,12,13,14,31,32,33,34-octahydro-2,6-dioxa-1(7,1),3(8,1)-diisoquinolina-5(1,3),7(1,4)-dibenzenacyclooctaphane
  • Tetrandrine AKSci J11730 AK Scientific
  • (+)-TETRANDRINE
  • NSC-77037|||d-Tetrandrine|||Hanfangchin A|||Fanchinine|||Sinomenine A
  • Tetrandrine (6CI, 7CI, 8CI)
  • (3S)-5-hydroxy-2,2,8-trimethyl-6-oxo-3,4-dihydro-2H,6H-pyrano[3,2-g]chromen-3-yl beta-D-glucopyranoside
  • 518-34-3
  • 18-34-3
  • Complex Molecules
  • Alphabetic
  • TA - TE
  • Analytical Chromatography Product Catalog
  • Analytical Standards
  • Chiral Building Blocks
  • Asymmetric Synthesis
Copyright 2019 © ChemicalBook. All rights reserved